— Organigram (NASDAQ: OGI) reported a net loss from continuing operations of $22.46 million for the fourth quarter of 2019, vs. profit of $18.9 million last year.

— Loss per share was $0.14, compared to earnings of $0.12 per share in the year-ago period

— Fourth-quarter net revenues surged to $16.3 million from $3.2 million last year

— Gross margin, before fair value changes to biological assets and inventories, dropped to $0.7 million from $1.6 million last year

— Adjusted EBITDA was (-)$7.9 million during the three-month period, compared $0.3 million a year earlier

— In the first quarter of 2020, net revenue is expected to increase sequentially on higher retail sales and wholesale revenue

— First-quarter gross margin, before fair value changes to biological assets and inventories, is anticipated to grow sequentially

— Expects the increased efficiencies and economies of scale to reduce cultivation costs in the first quarter, compared to Q4

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips